التفاصيل البيبلوغرافية
| العنوان: |
Intellectual disability syndrome associated with a homozygous founder variant in SGSM3 in Ashkenazi Jews. |
| المؤلفون: |
Birnbaum, Rivka, Ezer, Shlomit, Lotan, Nava Shaul, Eilat, Avital, Sternlicht, Keren, Benyamini, Lilach, Reish, Orit, Falik-Zaccai, Tzipora, Ben-Gad, Gali, Rod, Raya, Segel, Reeval, Kim, Katherine, Burton, Barabra, Keegan, Catherine E., Wagner, Mallory, Henderson, Lindsay B., Mor, Nofar, Barel, Ortal, Hirsch, Yoel, Meiner, Vardiella |
| المصدر: |
Journal of Medical Genetics; Mar2024, Vol. 61 Issue 3, p289-293, 5p |
| مستخلص: |
Background Neurodevelopmental disorders (NDDs) impact both the development and functioning of the brain and exhibit clinical and genetic variability. RAP and RAB proteins, belonging to the RAS superfamily, are identified as established contributors to NDDs. However, the involvement of SGSM (small G protein signalling modulator), another member of the RAS family, in NDDs has not been previously documented. Methods Proband-only or trio exome sequencing was performed on DNA samples obtained from affected individuals and available family members. The variant prioritisation process focused on identifying rare deleterious variants. International collaboration aided in the identification of additional affected individuals. Results We identified 13 patients from 8 families of Ashkenazi Jewish origin who all carried the same homozygous frameshift variant in SGSM3 gene. The variant was predicted to cause a loss of function, potentially leading to impaired protein structure or function. The variant co-segregated with the disease in all available family members. The affected individuals displayed mild global developmental delay and mild to moderate intellectual disability. Additional prevalent phenotypes observed included hypotonia, behavioural challenges and short stature. Conclusions An Ashkenazi Jewish homozygous founder variant in SGSM3 was discovered in individuals with NDDs and short stature. This finding establishes a connection between another member of the RAS family and NDDs. Additional research is needed to uncover the specific molecular mechanisms by which SGSM3 influences neurodevelopmental processes and the regulation of growth. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Medical Genetics is the property of BMJ Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder